{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:55:17Z","timestamp":1789779317710,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jocd.2024.101501","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:15:25Z","timestamp":1715310925000},"page":"101501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-8805","authenticated-orcid":false,"given":"Deep","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-5554","authenticated-orcid":false,"given":"Lakshmi","family":"Nagendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-8443","authenticated-orcid":false,"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-9371","authenticated-orcid":false,"given":"Saptarshi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8033-5748","authenticated-orcid":false,"given":"Satinath","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocd.2024.101501_bib0001","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jbspin.2005.10.002","article-title":"Central control of bone mass: potential therapeutic implications","volume":"72","author":"Levasseur","year":"2005","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.jocd.2024.101501_bib0002","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00198-015-3087-0","article-title":"Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density","volume":"26","author":"Veldhuis-Vlug","year":"2015","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2024.101501_bib0003","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/jc.2012-3625","article-title":"Changes in energy metabolism in pheochromocytoma","volume":"98","author":"Petr\u00e1k","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2024.101501_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-013-2498-z","article-title":"\u03b2-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects","volume":"25","author":"Toulis","year":"2014","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2024.101501_bib0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20102608","article-title":"Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual","volume":"208","author":"Kajimura","year":"2011","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.jocd.2024.101501_bib0006","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2017-00169","article-title":"Lower bone mass and higher bone resorption in pheochromocytoma: importance of sympathetic activity on human bone","volume":"102","author":"Kim","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2024.101501_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.06.023","article-title":"Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma","volume":"116","author":"Kim","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jocd.2024.101501_bib0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ijem.ijem_322_22","article-title":"Prevalence and Predictors of Osteoporosis\/BMD below expected range for age in pheochromocytoma\/paraganglioma and BMD, TBS change post-operatively: a prospective cohort study","volume":"27","author":"Khatiwada","year":"2023","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jocd.2024.101501_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115221","article-title":"Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis","volume":"133","author":"Yokomoto-Umakoshi","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2024.101501_bib0010","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jocd.2024.101501_bib0011","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3803\/EnM.2020.818","article-title":"Efficacy and safety of the novel dipeptidyl peptidase-4 inhibitor gemigliptin in the management of type 2 diabetes: a meta-analysis","volume":"36","author":"Dutta","year":"2021","journal-title":"Endocrinol Metab Seoul Korea"},{"issue":"10","key":"10.1016\/j.jocd.2024.101501_bib0012","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.jocd.2024.101501_bib0013","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jocd.2024.101501_bib0014","article-title":"Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis","volume":"17","author":"Dutta","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"7650","key":"10.1016\/j.jocd.2024.101501_bib0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jocd.2024.101501_bib0016","first-page":"1","article-title":"Publication and related biases","volume":"4","author":"Song","year":"2000","journal-title":"Health Technol Assess Winch Engl"},{"issue":"11","key":"10.1016\/j.jocd.2024.101501_bib0017","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2012-2823","article-title":"Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy","volume":"97","author":"Veldhuis-Vlug","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2024.101501_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115607","article-title":"Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma","volume":"142","author":"Yokomoto-Umakoshi","year":"2021","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.jocd.2024.101501_bib0019","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00018-018-2981-y","article-title":"Coupling factors involved in preserving bone balance","volume":"76","author":"Kim","year":"2019","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"7032","key":"10.1016\/j.jocd.2024.101501_bib0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","article-title":"Leptin regulation of bone resorption by the sympathetic nervous system and CART","volume":"434","author":"Elefteriou","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jocd.2024.101501_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11926-020-00892-w","article-title":"Update on imaging-based measurement of bone mineral density and quality","volume":"22","author":"Link","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.jocd.2024.101501_bib0022","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4103\/2230-8210.192914","article-title":"Bone turnover markers: emerging tool in the management of osteoporosis","volume":"20","author":"Shetty","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jocd.2024.101501_bib0023","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1210\/jc.2012-2381","article-title":"Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women","volume":"97","author":"Farr","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695024000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695024000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:46:17Z","timestamp":1722264377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695024000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1094695024000362"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2024.101501","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2024.101501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101501"}}